By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MIV Therapeutics Inc. 

8765 Ash Street, Unit #1

Vancouver  British Columbia  V6P 6T3  Canada
Phone: 604-301-9545 Fax: 604-301-9546


Medical Device

Company News
MIV Therapeutics Inc. (MIVT) Featured in Cardiovascular Business News 10/24/2008 8:06:44 AM
MIV Therapeutics Inc. (MIVT) Featured on Front Page of Medical Device Daily 10/23/2008 8:24:35 AM
Update: JACC Intervention Publishes MIV Therapeutics Inc. (MIVT)'s VESTASYNC I Trial Preliminary Results 10/21/2008 8:23:04 AM
MIV Therapeutics Inc. (MIVT) Announces Participation at TCT 2008 in Washington, D.C. 10/9/2008 12:45:29 PM
MIV Therapeutics Inc. (MIVT) CEO, Dr. Mark Landy To Be Featured as Panelist at Medical Design & Manufacturing Minneapolis Conference 9/18/2008 9:56:28 AM
MIV Therapeutics Inc. (MIVT) VESTAsync™ Drug-Eluting Stent Trials Progress 9/15/2008 9:54:22 AM
MIV Therapeutics Inc. (MIVT) Announces Exchange Offer for Reg. S Shareholders in Europe 8/15/2008 8:48:30 AM
MIV Therapeutics Inc. (MIVT) Announces Excellent Safety and Efficacy of VESTAsync(TM) Polymer-Free Drug-Eluting Stent at 12-Month Clinical Follow Up 8/5/2008 6:36:55 AM
MIV Therapeutics Inc. (MIVT) to Present at the BMO Capital Markets Focus On Healthcare Conference 7/30/2008 9:59:13 AM
MIV Therapeutics Inc. (MIVT) Provides Update on Its Next-Generation, Ultra-Thin Protea(TM) Stent Platform 7/16/2008 6:29:59 AM